Enterin Patents Novel Aminosterol ENT-03 Compounds and Compositions
Summary
The USPTO published patent application US20260098052A1 for Enterin, Inc., covering novel aminosterol ENT-03 compounds, compositions comprising the same, and methods of making and using the same. The inventors are Denise Barbut and Michael Zasloff. The application was filed December 10, 2025, under application number 19415736. The CPC classifications indicate therapeutic applications including nervous system conditions (A61P 25/00).
What changed
The USPTO published Enterin, Inc.'s patent application for novel aminosterol ENT-03 compounds and related compositions. The application covers the chemical compounds themselves as well as methods of making and using them, with CPC classifications indicating potential therapeutic applications including nervous system disorders (A61P 25/00).
Pharmaceutical companies and researchers should note this application as potential prior art when developing similar compounds. Legal professionals specializing in intellectual property should monitor the prosecution of this application to assess potential blocking positions or licensing opportunities.
What to do next
- Monitor for patent prosecution updates
- Review for freedom-to-operate implications
- Contact patent counsel to assess IP strategy
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HUMAN AMINOSTEROL ENT-03 COMPOUNDS, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME
Application US20260098052A1 Kind: A1 Apr 09, 2026
Assignee
Enterin, Inc.
Inventors
Denise Barbut, Michael Zasloff
Abstract
The present application relates generally to novel aminosterol compounds, compositions comprising the same, and methods of making and using the novel aminosterol compounds and compositions.
CPC Classifications
C07J 41/0005 A61K 31/575 A61P 25/00 C07J 9/005
Filing Date
2025-12-10
Application No.
19415736
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.